Illumina拟以最高4.25亿美元收购SomaLogic——BioPharma Dive报道
Illumina to buy SomaLogic in deal worth up to $425M - BioPharma Dive
生物技术与制药领域的最新动态
Illumina to buy SomaLogic in deal worth up to $425M - BioPharma Dive
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy - PR Newswire
Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics - Forbes
Video: Two Illumina scientists share their “why” - Illumina
Illumina widens access to cancer tests with Medicare and new CDx - Medical Device Network
Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis - Illumina
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies - PR Newswire
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents - GEN - Genetic Engineering and Biotechnology News
Comparative analysis of Illumina, PacBio, and nanopore for 16S rRNA gene sequencing of rabbit’s gut microbiota - Frontiers
SEC ends probe of Illumina’s Grail acquisition - MedTech Dive
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 - PR Newswire
Decode DNA and Methylation Together with Illumina's 5 Base Solution | Interview with Fiona Kaper - Illumina
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PR Newswire
Illumina Connected Multiomics - Illumina
Illumina board adds activist investor, elevates Scott Gottlieb to chair - Fierce Biotech
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors - PR Newswire
Illumina DNA Prep product line | Fast, flexible library prep - Illumina
Streamlined Multiomics Data Analysis Leveraging Illumina Software on AWS - Amazon Web Services (AWS)
How Illumina designs a gene sequencer - Illumina
Illumina aims to cut $100M in costs following China import ban - Fierce Biotech